Answers are grounded in this paper and cite their sources.
Investigates NK cell characteristics in acquired aplastic anemia, revealing important insights for targeted therapies.
Acquired aplastic anemia (AA) serves as a life-threatening hematopoietic disorder with certain morbidity and mortality, which is caused by the immunologic attack-induced lymphocyte destruction of hematopoietic stem/progenitor cells (HSPCs). Longitudinal studies have highlighted the immunodysfunction in the relapse of AA, yet the dissection of natural killer (NK) cell-related pathogenesis remains largely obscure. In this study, we enriched bone marrow blood-derived mononuclear cells (BM-MNCs) for 20 AA patients and 20 healthy donors (HD), and detected the content and immunophenotyping of resident NK cells (rHD-NKs, rAA-NKs) by cell counting and flow cytometry (FCM) assay. Meanwhile, we utilized our well-established “3ILs”-based protocol for the ex vivo induction of expanded NK cells from BM-MNCs (eHD-NKs, eAA-NKs). Besides the cellular phenotyping analyses of eHD-NKs and eAA-NKs, we further compared the cellular viability and the ex vivo cytotoxicity upon tumor cell lines. Finally, with the aid of RNA-sequencing (RNA-SEQ) and bioinformatics analyses, the transcriptomic signatures of eHD-NKs and eAA-NKs were verified, including gene expression profiling and genetic spectrum. Compared to the corresponding HD-NKs (rHD-NKs, eHD-NKs), both the resident and expanded AA-NKs (rAA-NKs, eAA-NKs) were consistently declined in content of total CD3 − CD56 + NK cells and the NKp46 + activated subset, while the CD3 − CD56 + CD16 + NK cells and the relative subsets revealed different trends (e.g., CD25 + , NKp44 + NK subsets). Meanwhile, eHD-NKs and eAA-NKs exhibited multifaceted conservations and alterations in gene expression pattern and somatic variation signatures. Overall, these data indicated the similarities and diversities of cellular phenotype and transcriptomic signatures between HD-NKs and AA-NKs in the bone marrow microenvironment. Our findings provided useful references for the bone marrow failure (BMF)-related cytogenetic characterization of AA-NKs, which would facilitate the further development of NK cell-based precise diagnosis and targeted therapeutics for AA in the future.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: